ReviewFrontiers in physiology2014

Mechanistic target of rapamycin (mTOR): a point of convergence in the action of insulin/IGF-1 and G protein-coupled receptor agonists in pancreatic cancer cells.

Enrique RozengurtPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.